|

MIECC vs Conventional Cardiopulmonary Bypass and Systemic Inflammation in CABG

RECRUITINGSponsored by Bursa Yuksek Ihtisas Training and Research Hospital
Actively Recruiting
SponsorBursa Yuksek Ihtisas Training and Research Hospital
Started2026-02-07
Est. completion2026-12-31
Eligibility
Age30 Years – 70 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT07823400

Summary

This prospective observational study evaluates the effects of minimally invasive extracorporeal circulation (MIECC) and conventional cardiopulmonary bypass on systemic inflammatory response in patients undergoing coronary artery bypass graft surgery. Adult patients undergoing elective coronary artery bypass surgery will be observed according to the extracorporeal circulation technique used during surgery. Systemic inflammation will be assessed using routinely available hematologic inflammatory indices, including the neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and systemic immune-inflammation index (SII). These parameters will be evaluated preoperatively, at postoperative 6 hours, at postoperative 24 hours, and at hospital discharge. The study will also evaluate selected perioperative and postoperative clinical outcomes in order to compare the inflammatory response associated with MIECC and conventional extracorporeal circulation.

Eligibility

Age: 30 Years – 70 YearsHealthy volunteers accepted
Inclusion Criteria:

* Age 30-70 years
* Patients undergoing elective coronary artery bypass graft surgery
* Patients in whom cardiopulmonary bypass is planned
* Written informed consent obtained

Exclusion Criteria:

* Emergency surgery
* Redo cardiac surgery
* Concomitant valve surgery
* Previous open heart surgery
* Preoperative renal and/or hepatic failure
* Malignancy
* Active infection or inflammatory disease-

Conditions3

Coronary Artery DiseaseHeart DiseaseSystemic Inflammation

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.